Matches in Ubergraph for { <http://purl.obolibrary.org/obo/NCIT_C163992> ?p ?o ?g. }
Showing items 1 to 55 of
55
with 100 items per page.
- NCIT_C163992 IAO_0000115 "A humanized monoclonal antibody directed against the immunosuppressive ligand programmed cell death-1 ligand 1 (PD-L1; cluster of differentiation 274; CD274), with potential immune checkpoint inhibitory and antineoplastic activities. Upon administration, tagitanlimab specifically targets and binds to PD-L1, blocking its binding to and activation of its receptor programmed cell death 1 (PD-1; cluster of differentiation 279; CD279). This reverses T-cell inactivation caused by PD-1/PD-L1 signaling and enhances the cytotoxic T-lymphocyte (CTL)-mediated anti-tumor immune response against PD-L1-expressing tumor cells. PD-L1 is overexpressed by many human cancer cell types. PD-L1 binding to PD-1 on T-cells suppresses the immune system and results in immune evasion. PD-1, a transmembrane protein belonging to the immunoglobulin superfamily (IgSF) expressed on activated T-cells, is a negative regulator of the immune system that limits the expansion and survival of CD8-positive T-cells." @default.
- NCIT_C163992 NCIT_A32 NCIT_C1909 @default.
- NCIT_C163992 NCIT_A7 NCIT_C96024 @default.
- NCIT_C163992 NCIT_NHC0 "C163992" @default.
- NCIT_C163992 NCIT_P106 "Pharmacologic Substance" @default.
- NCIT_C163992 NCIT_P108 "Tagitanlimab" @default.
- NCIT_C163992 NCIT_P208 "CL977261" @default.
- NCIT_C163992 NCIT_P210 "2417649-97-7" @default.
- NCIT_C163992 NCIT_P319 "GUY458P83P" @default.
- NCIT_C163992 NCIT_P322 "FDA" @default.
- NCIT_C163992 NCIT_P322 "GDC" @default.
- NCIT_C163992 NCIT_P329 "799136" @default.
- NCIT_C163992 NCIT_P330 "799136" @default.
- NCIT_C163992 NCIT_P375 "Anti-PD-L1 Monoclonal Antibody A167" @default.
- NCIT_C163992 NCIT_P399 "799136" @default.
- NCIT_C163992 NCIT_R124 NCIT_C17710 @default.
- NCIT_C163992 NCIT_R124 NCIT_C17828 @default.
- NCIT_C163992 NCIT_R124 NCIT_C18219 @default.
- NCIT_C163992 NCIT_R124 NCIT_C19986 @default.
- NCIT_C163992 NCIT_R124 NCIT_C40474 @default.
- NCIT_C163992 normalizedInformationContent "100" @default.
- NCIT_C163992 referenceCount "1" @default.
- NCIT_C163992 hasExactSynonym "A 167" @default.
- NCIT_C163992 hasExactSynonym "A-167" @default.
- NCIT_C163992 hasExactSynonym "A167" @default.
- NCIT_C163992 hasExactSynonym "Anti-PD-L1 Monoclonal Antibody A167" @default.
- NCIT_C163992 hasExactSynonym "KL A167" @default.
- NCIT_C163992 hasExactSynonym "KL-A167" @default.
- NCIT_C163992 hasExactSynonym "KLA167" @default.
- NCIT_C163992 hasExactSynonym "TAGITANLIMAB" @default.
- NCIT_C163992 hasExactSynonym "Tagitanlimab" @default.
- NCIT_C163992 inSubset NCIT_C128784 @default.
- NCIT_C163992 inSubset NCIT_C157711 @default.
- NCIT_C163992 inSubset NCIT_C157712 @default.
- NCIT_C163992 inSubset NCIT_C176424 @default.
- NCIT_C163992 inSubset NCIT_C177537 @default.
- NCIT_C163992 inSubset NCIT_C63923 @default.
- NCIT_C163992 type Class @default.
- NCIT_C163992 isDefinedBy ncit.owl @default.
- NCIT_C163992 label "Tagitanlimab" @default.
- NCIT_C163992 subClassOf NCIT_C128057 @default.
- NCIT_C163992 subClassOf NCIT_C129821 @default.
- NCIT_C163992 subClassOf NCIT_C129822 @default.
- NCIT_C163992 subClassOf NCIT_C141144 @default.
- NCIT_C163992 subClassOf NCIT_C143250 @default.
- NCIT_C163992 subClassOf NCIT_C156893 @default.
- NCIT_C163992 subClassOf NCIT_C163758 @default.
- NCIT_C163992 subClassOf NCIT_C163992 @default.
- NCIT_C163992 subClassOf NCIT_C1908 @default.
- NCIT_C163992 subClassOf NCIT_C1909 @default.
- NCIT_C163992 subClassOf NCIT_C191689 @default.
- NCIT_C163992 subClassOf NCIT_C20401 @default.
- NCIT_C163992 subClassOf NCIT_C274 @default.
- NCIT_C163992 subClassOf NCIT_C307 @default.
- NCIT_C163992 subClassOf NCIT_C308 @default.